首页|期刊导航|中国癌症杂志|磷酸肌酸代谢在肿瘤研究中的新进展

磷酸肌酸代谢在肿瘤研究中的新进展OA

Recent advances in phosphocreatine metabolism and its role in cancer research

中文摘要英文摘要

磷酸肌酸(phosphocreatine,PCr)作为细胞内的高能磷酸化合物,传统上被认为主要通过肌酸激酶系统在高能量需求时为细胞提供快速的能量缓冲.然而,近年来的研究发现,PCr的功能并不仅限于此,它在肿瘤代谢中扮演多重角色,尤其在肿瘤细胞干性的维持、表观遗传调控、代谢重塑及耐药性形成中发挥重要作用.PCr不仅支持肿瘤细胞快速增殖所需的能量供给,还通过调控关键蛋白的稳定性,影响染色体分离、细胞周期调控等进程.此外,PCr代谢可作为治疗靶点,通过抑制其合成途径显著抑制肿瘤生长,并与现有表观遗传抑制剂表现出协同作用,为肿瘤的治疗提供了新的策略.本综述围绕PCr调控肿瘤细胞增殖、迁移和侵袭,PCr在肿瘤干性维持及表观遗传重塑中的核心作用,PCr参与肿瘤耐药性的分子通路,以及靶向PCr代谢的抗肿瘤治疗新策略等最新进展展开,系统总结PCr代谢在肿瘤发生、发展及治疗中的研究新进展,分析其在肿瘤细胞生物学中的多重功能,并探讨其在靶向治疗中的潜在应用价值.

Phosphocreatine(PCr),traditionally recognized as an intracellular high-energy phosphate compound,mainly functions as a rapid energy buffer through the creatine kinase system to meet the high-energy demands of cells.However,recent studies have revealed that the role of PCr extends beyond this conventional view;it plays multiple roles in tumor metabolism,especially in maintaining tumor stem cell stemness,regulating epigenetics,remodeling metabolism,and contributing to drug resistance.PCr not only supports the energy supply required for the rapid proliferation of tumor cells but also affects processes such as chromosome segregation and cell cycle regulation by modulating the stability of key proteins.Moreover,PCr metabolism can serve as a therapeutic target,where inhibiting its synthesis pathway significantly suppresses tumor growth and exhibits synergistic effects with existing epigenetic inhibitors,providing new strategies for cancer therapy.This review focuses on the latest advancements including the regulation of tumor cell proliferation,migration,and invasion by PCr,its core role in maintaining tumor stemness and epigenetic remodeling,its involvement in the molecular pathways of tumor drug resistance,and new strategies for anti-tumor therapy targeting PCr metabolism.This review systematically summarizes the recent progress in PCr metabolism in tumorigenesis,tumor progression,and treatment,analyzes its multifaceted functions in tumor cell biology,and explores its potential application value in targeted therapy.

董皓轩;赵梦洁;刘亮;钱春发

南京医科大学附属脑科医院神经外科,江苏 南京 210003南京脑科医院神经精神疾病研究所,江苏 南京 210003南京医科大学附属脑科医院神经外科,江苏 南京 210003南京医科大学附属脑科医院神经外科,江苏 南京 210003

医药卫生

磷酸肌酸肌酸激酶肿瘤代谢肿瘤干细胞耐药性靶向治疗

PhosphocreatineCreatine kinaseTumor metabolismTumor stem cellsDrug resistanceTargeted therapy

《中国癌症杂志》 2026 (5)

496-500,5

国家自然科学基金(82403956,82203637). National Natural Science Foundation of China(82403956,82203637).

10.19401/j.cnki.1007-3639.2026.05.008

评论